Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVernalis PLC Regulatory News (VER)

  • There is currently no data for VER

AGM Statement

23 May 2007 11:49

Vernalis PLC23 May 2007 23 May 2007 VERNALIS PLC RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 23 MAY 2007 Vernalis plc announces that all resolutions proposed to shareholders at itsAnnual General Meeting held today were duly passed. All resolutions were approved on a show of hands. The number of proxy votesreceived for each resolution is set out below. Resolution For (including Against* Withheld discretionary votes)*Ordinary Resolution1. To receive theaudited accounts and related reports of theDirectors and auditors 224,569,857 (99.99%) 10,707 (0.01%) 7,1572. To approve theremuneration report 217,328,467 (99.63%) 813,306 (0.37%) 6,445,9483. To re-elect as a Director Dr A Baxter 224,545,392 (99.99%) 33,176 (0.01%) 9,1534. To re-elect as a Director Ms C C Ferguson 224,544,267 (99.98%) 38,844 (0.02%) 4,6105. To re-elect asa Director Mr J AD Slater 224,553,615 (99.99%) 28,646 (0.01%) 5,4606. To elect as aDirector Mr I Clark 224,542,703 (99.98%) 35,049 (0.02%) 9,9697. To re-appointPricewaterhouseCoopers LLP as auditors and to authorise the Directors to determine their remuneration 223,611,362 (99.65%) 792,957 (0.35%) 183,4028. To authorise the Directors to allot relevantsecurities 224,537,200 (99.98%) 37,797 (0.02%) 12,724Special Resolution9. To authorise the Directors to allot equitysecurities for cash 224,527,782 (99.98%) 39,519 (0.02%) 20,420Ordinary Resolution10. To approve the Vernalis plc Bonus Long-TermIncentive Plan 199,330,753 (91.39%) 18,789,501 (8.61%) 6,467,467 *NB: Percentage of votes cast excludes withheld votes Enquiries: Vernalis plc +44 (0)118 977 3133Simon Sturge, Chief Executive OfficerTony Weir, Chief Financial Officer Brunswick Group +44 (0)20 7404 5959Jon ColesAlex Tweed This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
16th Mar 20067:02 amRNSPhase IIa Trial of V1003
16th Mar 20067:02 amRNSPreliminary Results
27th Feb 200610:40 amRNSNotice of Results
24th Jan 20067:00 amRNSLaunch of US Sales Force
21st Dec 20052:30 pmRNSDirector/PDMR Shareholding
21st Dec 200511:19 amRNSHolding(s) in Company
20th Dec 20053:38 pmRNSHolding(s) in Company
20th Dec 20057:00 amRNSFrova Safety Study Completed
19th Dec 20057:01 amRNSOncology Collaboration
14th Dec 20058:23 amRNSCompletion - Cita Acquisition
13th Dec 200511:56 amRNSResults of EGM
12th Dec 200511:49 amRNSHolding(s) in Company
24th Nov 20055:00 pmRNSHolding(s) in Company
23rd Nov 20052:27 pmRNSHolding(s) in Company
18th Nov 20057:01 amRNSProposed acquisition of Cita
11th Nov 20054:01 pmRNSHolding(s) in Company
4th Nov 20057:01 amRNSCollaboration with Britannia
4th Nov 20057:01 amRNSVernalis Acquires Apokyn(R)
10th Oct 200512:47 pmRNSHolding(s) in Company
22nd Sep 20057:01 amRNSAppointment of Piper Jaffray
22nd Sep 20057:01 amRNSInterim Results
16th Sep 200512:30 pmRNSHolding(s) in Company
6th Sep 20057:00 amRNSFrovatriptan Phase III
8th Aug 20053:00 pmRNSHolding(s) in Company
27th Jul 20053:35 pmRNSHolding(s) in Company
26th Jul 20057:00 amRNSIonix acquisition completed
6th Jul 20057:00 amRNSAcquisition of Ionix
30th Jun 20055:23 pmRNSHolding(s) in Company
27th Jun 20057:00 amRNSMRM Interim Phase 3 Data
10th Jun 20055:49 pmRNSHolding(s) in Company
7th Jun 20057:00 amRNSVernalis Appoints Head of US
25th May 20053:00 pmRNSResults of the AGM
23rd May 20054:12 pmRNSHolding(s) in Company
26th Apr 20057:00 amRNSAnnual Report and Accounts
22nd Apr 20054:55 pmRNSHolding(s) in Company
13th Apr 20052:30 pmRNSDirector Shareholding
12th Apr 20051:30 pmRNSEndo/Serena launch RALLY
31st Mar 20054:30 pmRNSHolding(s) in Company
31st Mar 20054:30 pmRNSHolding(s) in Company
31st Mar 20057:00 amRNSOncology Research
21st Mar 200510:29 amRNSResult of EGM
24th Feb 20057:04 amRNSPlacing and Open Offer
24th Feb 20057:04 amRNSCo-promotion of Frova
24th Feb 20057:03 amRNSPreliminary Announcement
14th Feb 20054:58 pmRNSHolding(s) in Company
19th Jan 20057:00 amRNSStarts Clinical Trials

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.